Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 32.1% in May

Terumo Corp. (OTCMKTS:TRUMY) saw a significant decline in short interest in May. As of May 31st, there was short interest totalling 20,500 shares, a decline of 32.1% from the May 15th total of 30,200 shares. Based on an average daily trading volume, of 210,100 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

Terumo Price Performance

Shares of Terumo stock opened at $17.97 on Thursday. The firm has a market cap of $26.61 billion, a PE ratio of 34.56 and a beta of 0.80. The stock has a 50 day moving average of $18.75 and a 200 day moving average of $18.83. The company has a current ratio of 3.00, a quick ratio of 1.78 and a debt-to-equity ratio of 0.12. Terumo has a 12 month low of $14.06 and a 12 month high of $21.22.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.07). Terumo had a return on equity of 8.48% and a net margin of 11.28%. The business had revenue of $1.79 billion during the quarter, compared to the consensus estimate of $1.79 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.